TREM2 Mediates Microglial Anti-Inflammatory Activations in Alzheimer’s Disease: Lessons Learned from Transcriptomics

Alzheimer’s disease (AD) is a lethal neurodegenerative disorder primarily affecting the aged population. The etiopathogenesis of AD, especially that of the sporadic type, remains elusive. The triggering receptor expressed on myeloid cells 2 (TREM2), a member of TREM immunoglobulin superfamily, plays...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Feng, Du, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913972/
https://www.ncbi.nlm.nih.gov/pubmed/33557250
http://dx.doi.org/10.3390/cells10020321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913972/
https://www.ncbi.nlm.nih.gov/pubmed/33557250
http://dx.doi.org/10.3390/cells10020321

Ejemplares similares